Fibrogen Inc. (FGEN)

Trade FGEN now with
1/6/2020 7:14:32 AM FibroGen Appoints Enrique Conterno As CEO And Member Of Board
12/23/2019 7:11:08 AM FibroGen Submits NDA For Roxadustat In Patients With Anemia Of Chronic Kidney Disease
11/5/2019 10:33:29 PM Duke Realty Announces Pricing Terms For $400 Mln Senior Unsecured Notes Offering
9/26/2019 7:14:37 AM FibroGen Says First Patient Dosed In Phase 2 Clinical Study Of Roxadustat
9/20/2019 3:10:45 AM X5 Retail Announces Opening Of First New-concept Pyaterochka Store
9/20/2019 3:01:37 AM Evrenzo Tablets Approved In Japan For Anemia Associated With Chronic Kidney Disease In Dialysis Patients
7/22/2019 7:03:42 AM FibroGen Announces First Patient Dosed In ZEPHYRUS, A Phase 3 Clinical Trial Of Pamrevlumab
6/28/2019 7:07:59 AM FibroGen To Present Interim Phase 2 Data Or Pamrevlumab At Parent Project Muscular Dystrophy 2019 Annual Conference
12/20/2018 7:11:02 AM FibroGen Announces Positive Topline Results From Three Global Phase 3 Trials Of Roxadustat
12/6/2018 4:01:22 AM FibroGen Appoints Maykin Ho To Board Of Directors
10/1/2018 8:10:40 AM Astellas Submits NDA In Japan Of Roxadustat For Anemia Associated With Chronic Kidney Disease In Patients On Dialysis
9/12/2018 9:30:40 AM FibroGen Receives Fast Track Designation From FDA For Pamrevlumab For Treatment Of Idiopathic Pulmonary Fibrosis